Asthma is the most common chronic condition in Australian general practice, affecting around 2.7 million people per the ABS. It's also the most under-reviewed care plan in our specialty.

Why annual reviews aren't enough

Asthma is a fluctuating disease. Pollen counts, viral seasons, indoor heating, lifestyle changes — all of these shift control month to month. A care plan reviewed once a year describes a disease state from 11 months ago.

The clinical answer is quarterly reviews tied to symptom changes. The practical blocker is the same as every other care plan: nobody's tracking who's due.

The numbers that should trigger a review

  • FEV1 drop of more than 10% from the patient's personal best.
  • More than two reliever uses per week without a prior agreed action.
  • Any overnight wakening due to symptoms.
  • An ED presentation or oral corticosteroid course in the last 12 months.
  • Pregnancy onset, or planned pregnancy — control standards shift.

What goes into a good asthma plan

The four-zone written asthma action plan is still the standard (RACGP / Asthma Australia 2024). What changes with digital tooling: the plan lives on the patient's phone, the reliever-use log syncs from their device, and the GP sees the actual usage pattern at the next review — not the patient's recollection of it.

We've found patients consistently underestimate reliever use when self-reporting. Logged usage tells a more accurate story, and that story directs the controller dose.

Quarterly reviews with patient symptom + reliever data feeding in.See asthma in MedMETs